Effect of Naloxone on Plasma Beta-Endorphin and Vasoactive Intestinal Peptide in Neonatal Asphyxia

王颖,刘宝琴,郭在晨,李万镇
DOI: https://doi.org/10.3760/j.issn:0578-1310.2002.06.009
2002-01-01
Abstract:Objective To study the changes in plasma beta endorphin (β EP) and vasoactive intestinal peptide (VIP) in asphyxiated infants and the impact of naloxone on such changes. Methods Forty four infants with neonatal asphyxia (25 mild and 19 serious cases) were divided into naloxone treated asphyxia group ( n =32) and asphyxia control group ( n =12). Sixteen newborns were in non asphyxia control group. Blood samples were obtained within the first 24 hours of life for the measurement of plasma β EP and VIP levels. In naloxone treated asphyxia group, 0.05 mg/kg naloxone was given and repeated every 8 hours for a duration of 72 hours. Before naloxone treatment and 1 hour and 3 days after the treatment, blood samples were taken to measure plasma β EP and VIP levels. In non asphyxia control group blood samples were obtained at 1 hour and 4 days after birth, respectively. The plasma levels of β EP and VIP of all neonates were measured by RIA. Results Within the first 24 hours, the levels of plasma β EP and VIP were high in asphyxiated infants, and they had positive correlation with those of controls ( P 0.05). The levels of β EP and VIP were (165±61) ng/L and (91±45) ng/L in severe asphyxiated infants, (101±29) ng/L and (73±14) ng/L in mild asphyxiated infants, and (67±16) ng/L and (64±11) ng/L in non asphyxia controls, respectively. After 1 hour treatment, the levels of β EP and VIP in plasma dropped and they were lower than those of asphyxia controls. After 3 days of naloxone treatment, levels of β EP [(58±18) ng/L] and VIP [(50±13) ng/L] in naloxone treated asphyxia group were lower than those of asphyxia controls [β EP (77±15) ng/L and VIP (70±12)ng/L]. There was no significant difference in levels of β EP and VIP in plasma between naloxone treated asphyxia group and non asphyixia control group after 3 days of naloxone treatment. Conclusion The levels of β EP and VIP in plasma had a positive correlation with the severity of perinatal asphyxia. Naloxone could effectively reduce plasma β EP and VIP levels.
What problem does this paper attempt to address?